Pipeline and approval signals
Search agency notices, approvals, recalls, and regulatory updates from global authorities.
1,099 of 1,099 tracked regulatory updates from 40 agencies and publishers, page 11 of 22.
Field Safety Notices: 27 to 31 January 2025MHRA UKRegister medical devices to place on the marketMHRA UKCounterfeit weight loss pens worth £2 million seized by MHRA and West Midlands PoliceMHRA UKDecision: Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredientsMHRA UKMHRA introduces new safeguards to strengthen antidepressant safety information following major reviewMHRA UKAntidepressants: new safety measures for all patients to improve communication of the risk of suicidal thoughts and behaviours and persistent sexual dysfunctionMHRA UKResearch: Antidepressants – updated safety communicationsMHRA UKSafety Public Assessment ReportsMHRA UKGuidance: Antidepressants: use and safetyMHRA UKGood laboratory practice (GLP) for safety tests on chemicalsMHRA UKGuidance: MHRA Strategy to 2030: What it means for youMHRA UKMHRA 2030 Strategy to modernise patient-centred regulation for the era of AI and personalised medicinesMHRA UKCorporate report: MHRA Strategy 2030MHRA UKMedicines: apply for a variation to your marketing authorisationMHRA UKMHRA authorises Onswik (insulin efsitora alfa) for adults with type 2 diabetesMHRA UKContinuous renal replacement therapy (CRRT): Consider delayed administration of concurrent echinocandins, such as caspofungin, to reduce the risk of adsorption onto new polyacrylonitrile (PAN)-based filter membranes DSI/2026/014MHRA UKClass 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion, EL(26)A/42MHRA UKField Safety Notices for October 2026MHRA UKElectronic Application Forms (eAF) for UK medicines licensing applicationsMHRA UKField Safety Notices: 8 -12 June 2026MHRA UKGuidance: International Recognition ProcedureMHRA UKGuidance: MHRA Real-World Evidence: knowledge and guidanceMHRA UKField Safety Notices: 28 September 2026 to 2 October 2026MHRA UKResearch: Role of the Digital Mental Health Technology (DMHT) Working GroupMHRA UKResearch: Patient reported outcomes (PROs) resources for digital mental health technologies (DMHTs)MHRA UKMHRA Chair Professor Anthony Harnden: Bringing our strategy to life – listening, learning, and looking aheadMHRA UKFind product information about medicinesMHRA UKGuidance: Pneumococcal Vaccine Factsheet – Information for Patients, Parents and CarersMHRA UKFAGG sluit zich aan bij wereldwijde MedSafetyWeek-campagne met de oproep: ‘Negeer bijwerkingen niet, meld ze’.FAMHP BelgiumAkeegaFAMHP BelgiumLes analogues du GLP-1 et les doubles analogues GIP/GLP-1 : risques associés au mésusage et à l’utilisation hors indication pour la perte de poidsFAMHP BelgiumGarantir l’accès aux traitements aujourd’hui et préparer ceux de demainFAMHP BelgiumVitamine D3 (colécalciférol) : attention aux différents dosagesFAMHP BelgiumMatières premières: Soumettre une demande d’autorisation générale d'activitéFAMHP BelgiumSoHO EU PlatformFAMHP BelgiumInspection et autorisationFAMHP BelgiumSoHO critiquesFAMHP BelgiumPréparations à base de SoHOFAMHP BelgiumInformations généralesFAMHP BelgiumJascaydFAMHP BelgiumJascaydFAMHP BelgiumCampagne nationale de 10 jours sur les psychotropes : un usage adapté, à favoriser ensemble !FAMHP BelgiumÉtat d’avancement du « Plan de reprise pour la supervision des centres de fertilité » : actions réalisées et mesures en coursFAMHP BelgiumTepkinlyFAMHP BelgiumCampagne de vaccination contre la grippe saisonnière 2026-2027FAMHP BelgiumPRAC september 2026: veiligheidsonderzoek naar injecteerbare ijzerhoudende geneesmiddelenFAMHP BelgiumNouveau guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDRFAMHP BelgiumGuide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDRFAMHP BelgiumEnregistrement des antibiotiques dans VAMREG : e-learning pour les vétérinairesFAMHP Belgium50 ans de pharmacovigilance en Belgique : Save the DateFAMHP Belgium